1. Home
  2. SRTA vs LYEL Comparison

SRTA vs LYEL Comparison

Compare SRTA & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

N/A

Current Price

$4.73

Market Cap

472.4M

Sector

N/A

ML Signal

N/A

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

HOLD

Current Price

$21.80

Market Cap

490.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTA
LYEL
Founded
2014
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
472.4M
490.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SRTA
LYEL
Price
$4.73
$21.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$7.63
$25.00
AVG Volume (30 Days)
772.0K
95.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$61,000.00
Revenue This Year
$37.89
N/A
Revenue Next Year
$14.33
N/A
P/E Ratio
$9.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.85
$0.39
52 Week High
$6.02
$45.00

Technical Indicators

Market Signals
Indicator
SRTA
LYEL
Relative Strength Index (RSI) 51.97 41.25
Support Level $4.26 $21.27
Resistance Level $5.40 $27.30
Average True Range (ATR) 0.26 2.12
MACD 0.07 0.04
Stochastic Oscillator 65.38 23.84

Price Performance

Historical Comparison
SRTA
LYEL

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Share on Social Networks: